Pharmafile Logo
Pharmafocus logo
Advanced Search
national-cancer-institute-l8twzt4ccvq-unsplash_1

Swing Therapeutics receives FDA authorisation for digital therapeutic for fibromyalgia

May 22, 2023
Medical Communications CBT, Devices, FDA, Swing Therapeutics, fibromyalgia

Swing Therapeutics has announced that it has received De Novo marketing authorisation from the US Food and Drug Administration for …

News
brano-mm1vipqd0oa-unsplash

Krystal Biotech secures FDA approval for redosable topical gene therapy

May 22, 2023
Medical Communications FDA, Krystal Biotech, Paediatrics, dystrophic epidermolysis bullosa, gene therapy

US-based biotech company Krystal Biotech has announced that the US Food and Drug Administration (FDA) has approved its topical gene …

News
ed-us-k0dml4nmopo-unsplash

FDA committee votes in favour of Pfizer’s RSV vaccine for maternal immunisation

May 19, 2023
Research and Development FDA, Immunology, Pfizer, RSV, Vaccine, maternal immunisation

Pfizer has announced that the Vaccines and Related Biological Products Advisory Committee (VRBPAC) from the US Food and Drug Administration …

News

FDA approves Abbott’s Assert-IQ insertable cardiac monitor

May 19, 2023
Research and Development Abbott, Cardiology, Devices, FDA, heart monitor, medical devices

Abbott has announced that the US Food and Drug Administration (FDA) has granted its clearance for the Assert-IQ insertable cardiac …

News

Schott Pharma announces pre-filled polymer syringes for deep-cold medication

May 19, 2023
Medical Communications Devices, Schott Pharma, deep cold medication, syringe

Germany-based drug delivery solutions company Schott Pharma has announced its pre-fillable syringes (PFS) for drugs requiring deep-cold, such as those …

News
milad-fakurian-58z17lnvs4u-unsplash_2

NHS given guidance on offering genetic testing to stroke patients

May 19, 2023
Medical Communications NHS, Neurology, blood clot, genetic testing, stroke

The NHS has been given draft guidance on offering gene tests to patients who have had a stroke caused by …

News

Is the pharmaceutical sector prepared to face a titanium dioxide ban?

May 19, 2023
Manufacturing and Production ACG, EMA, EU, Titanium Dioxide

Dr Subhashis Chakraborty, head of Global Product Management, ACG Capsules In the wake of the ban on titanium dioxide (TiO2) …

News
Press release

NICE recommends Kapruvia for treatment of moderate-to-severe CKD-associated pruritus

May 18, 2023
Medical Communications Kapruvia, NICE, Nephrology, chronic kidney disease, pruritus

Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Cara Therapeutics have announced that the National Institute for Health and Care …

News

US appeals court hears arguments in abortion pill case

May 18, 2023
Medical Communications Obstetrics & Gynaecology, abortion, medication abortion, mifepristone, reproduction

The ongoing court battle surrounding the contested approval of mifepristone, one of the drugs used in medication abortions, has now …

News

Servier and Aitia enter into R&D collaboration for pancreatic cancer using Digital Twins

May 18, 2023
Research and Development Aitia, Digital Twins, Oncology, Pancreatic cancer, Servier

French pharmaceutical company Servier and US-based Causal AI and Digital Twins company Aitia have announced a collaboration to create Digital …

News

Asieris Pharmaceuticals and Uroviu announce strategic collaboration to further develop integrated diagnosis and treatment for bladder cancer

May 18, 2023
Research and Development Asieris Pharmaceuticals, Diagnostics, Oncology, Uroviu, bladder cancer, oncology

US-based biopharmaceutical company Asieris Pharmaceuticals and single-use endoscopic platform creator Uroviu have announced that they have entered into a strategic …

News

Nemours Children’s Health selected to conduct first gene therapy for Morquio A syndrome

May 17, 2023
Research and Development Morquio A syndrome, NIH, Nemours Children's Health, Paediatrics, gene therapy

Nemours Children’s Health, based in Delaware, US, has been chosen by the Foundation for the National Institutes of Health (FNIH) …

News

AstraZeneca announces positive results from phase 3 trial for Tagrisso plus chemotherapy

May 17, 2023
Research and Development AstraZeneca, Cancer, Oncology, Tagrisso, chemotherapy

AstraZeneca has announced positive results from the FLAURA2 phase 3 trial which showed that Tagrisso (osimertinib), in combination with chemotherapy, …

News

NICE recommends nine digital treatment options for depression and anxiety

May 17, 2023
Medical Communications NICE, Neurology, anxiety, depression, digital health, mental health

The National Institute for Health and Care Excellence (NICE) has recommended six digitally enabled therapies for adult patients with anxiety …

News

FDA grants Priority Review for Takeda’s cTTP treatment

May 17, 2023
Research and Development Biologics License Application, Cardiology, FDA, Takeda, cTTP

Japanese biopharmaceutical company Takeda has announced that the US Food and Drug Administration (FDA) has accepted its Biologics License Application …

News

RadioMedix and Orano Med complete patient enrolment for neuroendocrine cancer trial

May 16, 2023
Medical Communications Oncology, Orano Med, RadioMedix, neuroendocrine cancer, oncology

US-based RadioMedix and French Orano Med, two clinical stage radiopharmaceutical companies, have announced that the last patient has been enrolled …

News

Nido Biosciences raises $109m in funding for neurological diseases treatments

May 16, 2023
Sales and Marketing Financing, Neurology, Nido Biosciences, funding, neurology

US-based clinical-stage company Nido Biosciences has announced that is has received $109m in Seed, Series A and Series B financings, …

News

Astellas and Sony enter collaborative research agreement

May 16, 2023
Research and Development ADC, Astellas Pharma, Oncology, Sony, research agreement

Sony and Astellas Pharma have announced that they have entered into a collaborative research agreement in an attempt to discover …

News

uniQure announces sale of royalty interest in Hemgenix for up to $400m

May 16, 2023
Sales and Marketing Haematology, Hemgenix, haemophilia, royalties, uniQure

uniQure has announced that it has entered a definitive agreement to sell a portion of the royalty rights due to …

News

LaNova Medicines and AstraZeneca sign global exclusive license agreement for preclinical ADC

May 15, 2023
Research and Development ADC, AstraZeneca, LaNova Medicines, License Agreement, Oncology

Chinese biotechnology company LaNova Medicines and UK-based pharma company AstraZeneca have announced that they have signed a global exclusive license …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026